The effect of Salvia officinalis on lipid profile and quality of life in postmenopausal women

Effect of Salvia officinalis Tablet on lipid profile and quality of life in postmenopausal women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140622018187N12

Enrollment

102

Registered

2020-08-17

Start date

2014-05-22

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopausal and femal climacteric state. Menopausal and other perimenopausal disorders

Interventions

Intervention 1: Salvia officinalis extract, 100 mg tablet, three times daily for 8 weeks. Intervention 2: Placebo, tablets 100 mg, three times daily, 8 weeks.

Eligibility

Sex/Gender

Female

Age

45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 45 and 60 years Menstruation in the past year Conscious written consent No known physical or mental illness Do not take any hormonal medications to reduce menopausal symptoms in the past month Do not take lipid-lowering drugs BMI below 29 No history of allergy to herbal medicines No smoking, hookah or drug addiction

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cholesterol. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory.;Triglycerides. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory.;HDL. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory.;LDL. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory.	—

Measure

Time frame

Cholesterol. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory.;Triglycerides. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory.;HDL. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory.;LDL. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory.

—

Secondary

Measure	Time frame
Menopause Quality Of Life. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Menopause Quality Of Life Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSedighe Forouhari

Shiraz University of Medical Sciences

forouharism@yahoo.com+98 71 3647 4257

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026